NCT04172402 2025-07-22
NGS as the First-line Treatment in Advanced Biliary Tract Cancer
National Health Research Institutes, Taiwan
Phase 2 Completed
Clinical Trials
11 trialsNCT06978114 2025-07-02
A Study of BL-B01D1+PD-1/PD-L1 Monoclonal Antibody in Patients With Advanced Biliary Tract Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2 Recruiting
NCT06708858 2024-11-27
Phase â…¡ Clinical Study of Surufatinib Combined With Gemcitabine and Cisplatin Plus Durvalumab/Pembrolizumab Regimen in the Treatment of Advanced Biliary Tract Cancer
Chinese PLA General Hospital
Phase 2 Recruiting
NCT04727996 2024-04-19
BTC-BGB
Seoul National University Hospital
Phase 2 Active not recruiting
NCT05820906 2023-12-06
Cadonilimab Plus Regorafenib and Gem-Cis Chemotherapy in Advanced Biliary Tract Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT05812430 2023-09-13
Anlotinib Plus TQB2450 Combined With Nab-paclitaxel and Cisplatin as First-line Treatment for Advanced Biliary Tract Cancer
The First Affiliated Hospital of Zhengzhou University
Phase 2 Unknown
NCT05823987 2023-06-27
OPTIONS-05
Fudan University
Phase 2 Unknown
NCT04217954 2023-06-23
HAIC With Oxaliplatin, 5-FU and Bevacizumab Plus Intravenous Toripalimab for Advanced BTC
Peking University
Phase 2 Completed
NCT05781074 2023-03-24
CASTLE-08
Fudan University
Phase 2 Unknown
NCT05410197 2022-10-12
Envofolimab and Lenvatinib Combined With Gemcitabine Plus Cisplatin for Advanced BTC as First-Line Treatment(ENLIGHTEN)
Sun Yat-sen University
Phase 2 Unknown
NCT04027764 2019-07-22
Toripalimab Combined With S1 and Albumin Paclitaxel in Patients With Advanced Biliary Tract Cancer
Chinese PLA General Hospital
Phase 2 Unknown